Skip to main content
Figure 1 | BioData Mining

Figure 1

From: Computational genetics analysis of grey matter density in Alzheimer’s disease

Figure 1

An overview of our bioinformatics analysis pipeline. In phase I we focus on identifying those genes with statistically significant pairs of SNPs that are associated with the phenotype. These genetic effects can be additive or non-additive for each genes. The goal of Phase II was to use bioinformatics analysis with functional genomics data to reduce the possibility of false-positive results. A final genetic model is constructed and interpreted.

Back to article page